Literature DB >> 30471316

Association between atopic dermatitis and extracutaneous bacterial and mycobacterial infections: A systematic review and meta-analysis.

Linda Serrano1, Kevin R Patel1, Jonathan I Silverberg2.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is associated with increased bacterial colonization and infection of skin and multiple risk factors for extracutaneous infections. However, previous studies found conflicting results about whether AD is associated with increased extracutaneous infections.
OBJECTIVE: To determine whether extracutaneous bacterial and mycobacterial infections are increased in AD.
METHODS: A systematic review was performed of all published observational studies with controls in MEDLINE, EMBASE, Global Resource of EczemA Trials, Cochrane, and Web of Science that assessed extracutaneous infections in AD. Pooled meta-analysis was performed by using random-effects weighting.
RESULTS: Overall, 7 studies met inclusion criteria. All 7 studies found an increased odds for at least 1 extracutaneous infection, including endocarditis, meningitis, encephalitis, bone and joint infections, and sepsis, in AD patients. In pooled meta-analysis, AD in children and adults was associated with a higher odds of ear infection (odds ratio [OR] 1.29, 95% confidence interval [CI] 1.16-1.43), strep throat (OR 2.31, 95% CI 1.66-3.22), and urinary tract infection (OR 2.31, 95% CI 1.66-3.22) but not pneumonia (OR 1.72, 95% CI 0.75-3.98). No publication bias was detected. LIMITATIONS: Individual-level data were not available.
CONCLUSION: AD patients have higher odds of extracutaneous infections. Future studies are needed to confirm these associations and determine their mechanisms.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atopic dermatitis; eczema; serious infection; severity; systematic review

Mesh:

Year:  2018        PMID: 30471316     DOI: 10.1016/j.jaad.2018.11.028

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study.

Authors:  J Wan; D B Shin; M N Syed; K Abuabara; A R Lemeshow; J M Gelfand
Journal:  Br J Dermatol       Date:  2022-01-20       Impact factor: 11.113

2.  Tricuspid valve infective endocarditis in a non-IVDU patient with atopic dermatitis.

Authors:  Heerani Woodun; Sarah Bouayyad; Sura Sahib; Nadir Elamin; Steven Hunter; Abdallah Al-Mohammad
Journal:  Oxf Med Case Reports       Date:  2020-07-24

3.  Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.

Authors:  Lawrence F Eichenfield; Thomas Bieber; Lisa A Beck; Eric L Simpson; Diamant Thaçi; Marjolein de Bruin-Weller; Mette Deleuran; Jonathan I Silverberg; Carlos Ferrandiz; Regina Fölster-Holst; Zhen Chen; Neil M H Graham; Gianluca Pirozzi; Bolanle Akinlade; George D Yancopoulos; Marius Ardeleanu
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

4.  Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016.

Authors:  Richard J Silverwood; Kathryn E Mansfield; Amy Mulick; Angel Y S Wong; Sigrún A J Schmidt; Amanda Roberts; Liam Smeeth; Katrina Abuabara; Sinéad M Langan
Journal:  J Allergy Clin Immunol       Date:  2021-01-27       Impact factor: 10.793

5.  Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.

Authors:  J Beecker; K A Papp; J Dutz; R B Vender; R Gniadecki; C Cooper; P Gisondi; M Gooderham; C H Hong; M G Kirchhof; C W Lynde; C Maari; Y Poulin; L Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02-03       Impact factor: 6.166

6.  Study on the Molecular Basis of Huanglian Jiedu Decoction Against Atopic Dermatitis Integrating Chemistry, Biochemistry, and Metabolomics Strategies.

Authors:  Jing Chen; Saizhen Chen; Jinguang Chen; Bixin Shen; Zhengli Jiang; Yubin Xu
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

Review 7.  Dermatology for the internist: optimal diagnosis and management of atopic dermatitis.

Authors:  Shanthi Narla; Jonathan I Silverberg
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

8.  Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.

Authors:  Anne Weiss; Emilie Delavenne; Carina Matias; Heimo Lagler; Daniel Simon; Ping Li; Jon U Hansen; Teresa Pires Dos Santos; Bimal Jana; Petra Priemel; Christine Bangert; Martin Bauer; Sabine Eberl; Alina Nussbaumer-Pröll; Zoe Anne Österreicher; Peter Matzneller; Tamara Quint; Maria Weber; Hanne Mørck Nielsen; Thomas Rades; Helle Krogh Johansen; Henrik Westh; Wooseong Kim; Eleftherios Mylonakis; Christian Friis; Luca Guardabassi; John Pace; Carina Vingsbo Lundberg; Fatima M'Zali; Pascal Butty; Nikolaj Sørensen; Henrik Bjørn Nielsen; Rasmus Toft-Kehler; Emma Guttman-Yassky; Georg Stingl; Markus Zeitlinger; Morten Sommer
Journal:  Clin Transl Med       Date:  2022-05

9.  Association of Childhood Atopic Dermatitis with Extracutaneous Infections Based on the Nationwide Cross-Sectional Study in Korea.

Authors:  Hee Jae Park; Mira Choi
Journal:  Ann Dermatol       Date:  2022-08       Impact factor: 0.722

Review 10.  The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.

Authors:  H Alexander; A S Paller; C Traidl-Hoffmann; L A Beck; A De Benedetto; S Dhar; G Girolomoni; A D Irvine; P Spuls; J Su; J P Thyssen; C Vestergaard; T Werfel; A Wollenberg; M Deleuran; C Flohr
Journal:  Br J Dermatol       Date:  2019-12-04       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.